High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer

[1]  Zhiming Liu,et al.  Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1‐mediated lipid accumulation , 2019, Life sciences.

[2]  J. Trevino,et al.  Glucose and Lactate Transport in Pancreatic Cancer: Glycolytic Metabolism Revisited , 2018, Journal of oncology.

[3]  Han Liu,et al.  Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer , 2018, Computational and structural biotechnology journal.

[4]  B. Yan,et al.  Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1 , 2018, Cell proliferation.

[5]  Z. Wang,et al.  Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling , 2018, Cellular Physiology and Biochemistry.

[6]  F. Giorgino,et al.  Diabetes and cancer: Pathophysiological fundamentals of a 'dangerous affair'. , 2018, Diabetes research and clinical practice.

[7]  L. Young,et al.  Activation of sterol regulatory element‐binding protein 1 (SREBP1)‐mediated lipogenesis by the Epstein–Barr virus‐encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma , 2018, The Journal of pathology.

[8]  Xiaolong Wang,et al.  SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2 , 2018, Cell Death & Differentiation.

[9]  L. Young,et al.  Activation of SREBP1-mediated lipogenesis by the Epstein-Barr Virus-encoded LMP1 promotes cell proliferation and progression of nasopharyngeal carcinoma. , 2018 .

[10]  R. Peracaula,et al.  Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma , 2018, World journal of gastroenterology.

[11]  Jinlong Yu,et al.  Sterol regulatory element-binding protein 1 cooperates with c-Myc to promote epithelial-mesenchymal transition in colorectal cancer. , 2018, Oncology letters.

[12]  Z. Wang,et al.  Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions , 2018, Journal of experimental & clinical cancer research : CR.

[13]  K. Chiba,et al.  Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer , 2018, Cancers.

[14]  M. Zali,et al.  Systematic review of pancreatic cancer epidemiology in Asia-Pacific Region: major patterns in GLOBACON 2012 , 2017, Gastroenterology and hepatology from bed to bench.

[15]  J. Mayerle,et al.  Roles of autophagy and metabolism in pancreatic cancer cell adaptation to 1 environmental challenges , 2017 .

[16]  C. Lyssiotis,et al.  Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer. , 2017, Cancer cell.

[17]  I. Ilic,et al.  Epidemiology of pancreatic cancer , 2016, World journal of gastroenterology.

[18]  Wei Zhou,et al.  High risk factors of pancreatic carcinoma , 2016, Journal of Huazhong University of Science and Technology [Medical Sciences].

[19]  Q. Ma,et al.  Hyperglycemia Promotes the Epithelial-Mesenchymal Transition of Pancreatic Cancer via Hydrogen Peroxide , 2016, Oxidative medicine and cellular longevity.

[20]  Zhang Xiaochen,et al.  Autophagy is involved in regulating VEGF during high-glucose-induced podocyte injury. , 2016, Molecular bioSystems.

[21]  J. Guan,et al.  Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling. , 2016, Cancer research.

[22]  M. Cechowska-Pasko,et al.  Low glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF-7 cells , 2016, Molecular and Cellular Biochemistry.

[23]  Ke Chen,et al.  The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species , 2015, Oxidative medicine and cellular longevity.

[24]  Chang S. Chan,et al.  Autophagy, Metabolism, and Cancer , 2015, Clinical Cancer Research.

[25]  A. Chakravarti,et al.  Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth. , 2015, Cancer cell.

[26]  Liang Han,et al.  Hyperglycemic tumor microenvironment induces perineural invasion in pancreatic cancer , 2015, Cancer biology & therapy.

[27]  A. Harris,et al.  SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme , 2015, Oncogene.

[28]  Lorenzo Galluzzi,et al.  Metabolic Control of Autophagy , 2014, Cell.

[29]  R. Waldron,et al.  Diabetes, pancreatic cancer, and metformin therapy , 2014, Front. Physiol..

[30]  A. Renehan,et al.  Diabetes and cancer: 5 years into the recent controversy. , 2014, European journal of cancer.

[31]  Xiangyan Li,et al.  Fatostatin Displays High Antitumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling , 2014, Molecular Cancer Therapeutics.

[32]  Xin Zhang,et al.  Sterol regulatory element-binding protein 1 is required for ovarian tumor growth. , 2013, Oncology reports.

[33]  Geoffrey S. Tobias,et al.  Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium , 2013, Cancer Causes & Control.

[34]  T. Graeber,et al.  An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. , 2013, Cancer research.

[35]  A. Harris,et al.  Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth , 2013, Cancer & Metabolism.

[36]  W. Shao,et al.  Expanding roles for SREBP in metabolism. , 2012, Cell metabolism.

[37]  Bond-Smith Giles,et al.  Only women with symptoms need to have their breast implants removed, says government , 2012 .

[38]  Timothy F. Osborne,et al.  SREBPs: metabolic integrators in physiology and metabolism , 2012, Trends in Endocrinology & Metabolism.

[39]  Liang Han,et al.  Hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide. , 2011, Oncology reports.

[40]  T. Finkel,et al.  Metabolism meets autophagy , 2010, Cell cycle.

[41]  Patrick Maisonneuve,et al.  Epidemiology of pancreatic cancer: an overview , 2009, Nature Reviews Gastroenterology &Hepatology.

[42]  T. Shimosegawa,et al.  Chronic pancreatitis and pancreatic cancer: prediction and mechanism. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  S. Shrikhande,et al.  Pancreatic carcinogenesis: The impact of chronic pancreatitis and its clinical relevance. , 2009, Indian journal of cancer.

[44]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[45]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[46]  N. Bardeesy,et al.  Pancreatic adenocarcinoma. , 2014, The New England journal of medicine.

[47]  Han Liu,et al.  High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells , 2010, Molecular and Cellular Biochemistry.

[48]  Wolfgang Schima,et al.  Pancreatic adenocarcinoma , 2006, European Radiology.

[49]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[50]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.